Quality & complianceOfficial

FDA lists Class II recall of Victory Medical Center Pharmacy tesamorelin 10mg/ml product

🇺🇸 FDA enforcement report · Wed 11 Nov 2026

The US regulator's enforcement report cites lack of processing controls for the compounded product, which was distributed in Colorado, Florida and Texas and remains under recall.

The US Food and Drug Administration has published a Class II recall in its enforcement report for tesamorelin (MDV) 10mg/ml, 3ml presentation, from Victory Medical Center Pharmacy. The entry is dated 11 November 2026 and carries recall number D-0143-2027.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: FDA enforcement report ↗

Article written by VigiEye from the official source (FDA enforcement report). AI-assisted; check the source before acting.